title: Quantification of volume loss and haemodynamic changes of Gelofusine-induced anaphylaxis during cardiopulmonary bypass.
abstract: A patient undergoing anaesthesia for coronary artery bypass surgery developed what was subsequently confirmed to be an anaphylactic reaction to succinylated gelatin (Gelofusine). By virtue of being on cardiopulmonary bypass, rapid detection, quantification and treatment of volume loss (by vasodilatation and extravasation) was possible. The patient required 51 ml/kg of resuscitative fluids in the 15 minutes after onset of anaphylaxis, or 73% of her calculated preoperative blood volume. Alpha-adrenoceptor agonists and vasopressin were required to manage ongoing vasoplegia. This case emphasises the importance of volume resuscitation and vasopressors in the treatment of anaphylaxis.
authors.affiliation: Department of Anaesthesia, Sir Charles Gairdner Hospital, Nedlands, Western Australia. rclarke@meddent.uwa.edu.au
authors.forename: R
authors.initials: R
authors.lastname: Clarke
authors.forename: P
authors.initials: P
authors.lastname: Sadleir
authors.forename: A W
authors.initials: AW
authors.lastname: Van Niekerk
authors.forename: P
authors.initials: P
authors.lastname: Platt
mesh_terms: D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced* / Q000628:therapy; D001810:Blood Volume; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D010952:Plasma Substitutes / Q000009:adverse effects*; D011097:Polygeline / Q000009:adverse effects*
chemical_list: D010952:Plasma Substitutes; D011097:Polygeline